Recognition of and steps to mitigate anxiety and fear of pain in injectable diabetes treatment

Davida F Kruger,1 Susan LaRue,2,3 Phil Estepa31Henry Ford Health System, Detroit, MI, USA; 2Amylin Pharmaceuticals, San Diego, CA, USA; 3AstraZeneca, San Diego, CA, USAAbstract: Injectable treatments, such as glucagon-like peptide-1 receptor agonists and insulin, are options for the pharmacologic t...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kruger DF, LaRue S, Estepa P
Format: article
Langue:EN
Publié: Dove Medical Press 2015
Sujets:
Accès en ligne:https://doaj.org/article/c4101dd3e397480987d143c0013dfd54
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!